Charles Ryan
MD
Hematology and Oncology Division Director
👥Biography 个人简介
Charles Ryan led the PREVAIL trial demonstrating enzalutamide's benefit in chemotherapy-naive metastatic castration-resistant prostate cancer, contributing to its FDA approval and establishing it as a first-line standard. His foundational research on androgen receptor biology and resistance mechanisms in CRPC has shaped the treatment landscape for advanced prostate cancer.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-02-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Charles Ryan 的研究动态
Follow Charles Ryan's research updates
留下邮箱，当我们发布与 Charles Ryan（University of Minnesota）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment